Alligator Bioscience AB Share Price London S.E.
Stocks
0RK9
SE0024173637
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
London S.E.
11:55:48 18/12/2025 GMT
|
5-day change | 1st Jan Change | ||
| 0.3209 SEK | -99.99% |
|
+1,512.56% | -0.28% |
| 09-07 | Alerts on Alligator Bioscience conducting rights issue withdrawn | RE |
| 09-01 | Alligator Bioscience shares trade today on Nasdaq Stockholm ex-rights for units in rights issue | FW |
| Market Cap | 9.61M 961K 858K 798K 726K 1.37M 93.01M 1.38M 3.77M 47.42M 3.61M 3.53M 152M | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 9.61M 961K 858K 798K 726K 1.37M 93.01M 1.38M 3.77M 47.42M 3.61M 3.53M 152M | EV / Sales 2026 * |
1.63x | EV / Sales 2027 * | 0.19x |
| Free-Float |
48.53% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Alligator Bioscience AB
| 1 day | -99.99% | ||
| 1 week | +1,512.56% | ||
| Current month | +1,512.56% | ||
| 1 month | +1,313.66% | ||
| 3 months | +79.68% | ||
| 6 months | +71.60% | ||
| Current year | -0.28% |
| 1 week | 0.02 |  | 0.32 |
| 1 month | 0.02 | | 0.32 |
| Current year | 0.02 | | 0.42 |
| 1 year | 0.02 | | 4.44 |
| 3 years | 0.02 | | 1,508 |
| 5 years | 0.02 | | 2,508.4 |
| 10 years | 0.02 | | 34,002.21 |
| Manager | Title | Age | Since |
|---|---|---|---|
Søren Bregenholt
CEO | Chief Executive Officer | 55 | 31/05/2021 |
Johan Gileus
DFI | Director of Finance/CFO | 61 | 11/08/2024 |
Tom Moore
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | - | |
| Director/Board Member | 64 | 31/05/2021 | |
Denise Goode
BRD | Director/Board Member | 68 | 08/05/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -99.99% | +1,512.56% | - | - | 961K | |
| -2.59% | -5.70% | +50.69% | +86.86% | 70.61B | |
| +3.23% | -10.67% | +6.27% | +53.70% | 51.01B | |
| +1.56% | +1.17% | +8.49% | +31.81% | 48.1B | |
| +0.39% | +0.65% | +31.14% | +28.97% | 42.78B | |
| +0.87% | -8.17% | +293.37% | +642.41% | 40.67B | |
| +1.24% | -1.01% | +10.74% | +100.64% | 40.3B | |
| -2.13% | -1.64% | +8.63% | +46.88% | 30.59B | |
| -0.46% | -1.28% | +42.23% | +20.34% | 28.16B | |
| +5.32% | +0.06% | -5.00% | -12.78% | 24.36B | |
| Average | -9.26% | -2.66% | +49.62% | +110.98% | 41.84B | |
| Weighted average by Cap. | +0.56% | -2.94% | +51.35% | +115.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.9M 590K 527K 490K 446K 842K 57.1M 846K 2.31M 29.11M 2.22M 2.17M 93.43M | 49.7M 4.97M 4.44M 4.13M 3.76M 7.09M 481M 7.12M 19.47M 245M 18.66M 18.26M 787M |
| Net income | -15.2M -1.52M -1.36M -1.26M -1.15M -2.17M -147M -2.18M -5.96M -75.01M -5.71M -5.58M -241M | 28.9M 2.89M 2.58M 2.4M 2.18M 4.12M 280M 4.14M 11.32M 143M 10.85M 10.62M 458M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/10/26 | SEK 0.0163 | -7.91% | 500,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATORX Stock
- 0RK9 Stock
Select your edition
All financial news and data tailored to specific country editions
